• Subscribe
  • Advertise
  • Contact Us
June 16, 2025
Pharma News HQ


  • Home
  • News
  • Clinical Trials
  • Drug Development
  • Manufacturing
  • Packaging and Labeling
  • Cold Chain
  • Diseases
  • Technology
  • Press Feed
    • Articles
    • Press Releases
  • Events
Top Headlines
  • [ February 14, 2023 ] Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues Manufacturing
  • [ February 14, 2023 ] Genenta Science signs manufacturing deal with AGC Biologics Manufacturing
  • [ February 14, 2023 ] Vial and Egnyte announce partnership for eTMF solution integration Clinical Trials
  • [ February 14, 2023 ] SOPHiA GENETICS and AstraZeneca partner for oncology drugs development Drug Development
  • [ February 14, 2023 ] FDA suggests ways to curb constraints with rare disease gene therapy trials Clinical Trials
Home2018July

Month: July 2018

Drug Development

Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK development services

July 4, 2018 Pharma News HQ 0

US-based Catalent has agreed to acquire Juniper Pharmaceuticals in a deal valued at around $133m.As per terms of the deal, Juniper will purchase all outstanding shares of Juniper by paying $11.50 per share in cash.Juniper’s […]

Manufacturing

Abzena signs $5.9m manufacture agreement with Telix

July 4, 2018 Pharma News HQ 0

UK-based life sciences group Abzena has signed GMP manufacturing and bioconjugation agreements with Australia-based Telix Pharmaceuticals.The agreements have a combined value of $5.9 million and these projects are expected to be substantially completed within a […]

Drug Development

TRIGR Therapeutics and ABL Bio Announce Global Oncology Collaboration on Pipeline of Next Generation Therapeutic Antibodies

July 4, 2018 Pharma News HQ 0

TRIGR Therapeutics and ABL Bio have entered into a binding agreement for TRIGR to license the global commercial rights to ABL Bio’s pipeline of novel therapeutic antibodies to treat cancer.These therapeutic antibodies include ‘blood-brain barrier […]

Drug Development

Ionic liquids for addressing unmet needs in healthcare

July 3, 2018 Pharma News HQ 0

An oral insulin formulation has been developed using choline and geranate (CAGE) ionic liquid, which significantly reduces blood glucose levels in vivo for a sustained period, according to a study published online June 25 in […]

News

Nearly Half of At-Home DNA Test Results Could Be Wrong

July 3, 2018 Pharma News HQ 0

If you’re considering at-home DNA testing, there are some things you need to know, California State University experts say.The popular tests are found in nearly every drugstore in the country, ranging in price from $60 […]

Posts pagination

« 1 … 9 10 11 12 »



















  • Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

    February 14, 2023 0
  • Genenta Science signs manufacturing deal with AGC Biologics

    February 14, 2023 0
  • Vial and Egnyte announce partnership for eTMF solution integration

    February 14, 2023 0
  • SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

    February 14, 2023 0
  • FDA suggests ways to curb constraints with rare disease gene therapy trials

    February 14, 2023 0
Pharma News HQ

Pharma News HQ, the journal dedicated to the pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmanewshq.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production.

 

About Us

 

Subscribe

 

Contact US

Latest Post
  • Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

    February 14, 2023 0
  • Genenta Science signs manufacturing deal with AGC Biologics

    February 14, 2023 0
  • Vial and Egnyte announce partnership for eTMF solution integration

    February 14, 2023 0
  • SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

    February 14, 2023 0
  • FDA suggests ways to curb constraints with rare disease gene therapy trials

    February 14, 2023 0